Entrada Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | +138.7% | +602.6% | -17.6% | +86.1% | +12.2% | -28.3% | |
| – | +129.1% | +647.7% | -29.7% | +76.2% | +19.0% | -30.4% | |
| – | +131.8% | +645.5% | -84.5% | +49.7% | +49.7% | -10.7% | |
| – | +131.8% | +645.5% | -35.2% | +86.5% | +19.3% | -29.6% | |
| – | – | – | – | – | -37.4% | -30.0% | |
| – | – | – | – | – | – | – | |
| – | +279.2% | +106.2% | +427.4% | – | – | – | |
| – | +151.9% | -91.6% | +455.2% | +474.2% | -57.0% | -27.0% | |
| – | +74.9% | +100.0% | +227.0% | +622.7% | -75.1% | -38.1% | |
| – | – | – | – | -5.9% | -4.4% | -45.3% | |
| – | +125.6% | -55.9% | +748.4% | -45.3% | +30.0% | -46.3% | |
| – | – | – | -28.8% | +14.0% | +76.9% | -28.6% | |
| – | – | – | – | – | – | – | |
| – | +2,881.7% | -0.1% | +0.2% | +5.6% | +18.0% | +6.1% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.